Relationship between RECIST response and variation of circulating tumor cells (CTC) for patients enrolled in phase I trials.
Christophe Massard
Consultant or Advisory Role - Johnson & Johnson
Françoise Farace
No relevant relationships to disclose
Isabelle Borget
No relevant relationships to disclose
Christophe Le Tourneau
No relevant relationships to disclose
Jean-Yves Pierga
No relevant relationships to disclose
Francois Clement Bidard
No relevant relationships to disclose
Jean-Philippe Spano
No relevant relationships to disclose
Charles Ferte
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose